
Diffusion Optics Technology (DOT) spectacle lenses are intended to slow myopia progression in children via contrast management mechanism of action.

Diffusion Optics Technology (DOT) spectacle lenses are intended to slow myopia progression in children via contrast management mechanism of action.

Myopia management in children is a crucial step to ensuring the overall health and wellness of our youth.

Phase 3 of the randomized, double-masked, placebo-controlled study had a primary end point to evaluate the signs and symptoms of dry eye disease caused by Sjögren syndrome.

A new treatment option may be on the horizon for glaucoma patients.

Optometry Times chats with Michael Chaglasian, OD, FAAO during this year's Glaucoma 360 meeting in San Francisco, California.

Pairing the patient with the right therapy can yield dramatic results.

An investigative study of the Government Accountability Office was requested by a US House of Representatives committee to evaluate the consolidation and vertical integration of vision coverage.

The event, being held at the El Conquistador Resort in Puerto Rico, is offering programs for ophthalmologists and optometrists.

This article outlines which medications may be best to take to mitigate the onset of type 2 diabetes through weight loss, in addition to lessening sugar intake and other eating habits.

Robert L Stamper, MD, raises the question of physician liability for allowing the patient to drive.

Shan C. Lin, MD, discusses combined minimally invasive glaucoma surgery and its impact on achieving improved intraocular pressure efficacy.


OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.

Catch up on what happened in optometry during the week of February 5-February 9.

According to the company, AGTC-501 was generally safe and well-tolerated and showed improvements in visual function at the 12-month analysis. The Phase 2/3 VISTA trial for AGTC-501 in XLRP expected to begin in in the first half of 2024.

Members of the University Professional and Technical Employees CWA Local 9119 drew picket lines on February 6 and 7 to protest unfair labor and bargaining practices upheld by University of California.

Cecelia Koetting, OD, FAAO, DIPABO chats with Optometry Times about her role with EnVision Summit's new optometry program and the excitement surrounding the event.

A new study found that only a little over half of school-aged children participants underwent vision screening within the past two years, highlighting gaps in eye care access.

The study further defined the relationship between delayed rod-mediated dark adaptation and the status of outer retinal bands on optical coherence tomography.

Shamir unveils a new electro-optic measurement system that utilizes artificial intelligence and over 10 different cameras to measure pupillary distance, and announces a partnership renewal with BWT Alpine F1 Team.

Promotion of Integrated People-centered Eye Care and highlighting the need for an international approach to eye care initiatives is this year’s World Optometry Week topic.

By targeting tear evaporation, F6H8 ushers in a new era of dry eye treatment.

Walmart takes virtual try-ons to the next level by integrating augmented reality into its website and app for customers to try out prescription glasses frames virtually.

There may not be a standard regime to eradicate the parasites, but treatment options do exist.

Catch up on what happened in optometry during the week of January 29-February 2.

The companies have released a new INVU collection of sunglasses made from upcycled plastic featuring ultra polarized lenses.

In a news release, the FDA noted these are copycat eye drop products that consumers can easily mistake for Bausch + Lomb’s Lumify brand eye drops, an over-the-counter product approved for redness relief.

William Hogue, OD, MS, sat down with Optometry Times to outline what symptoms and risk factors eye care providers should look out for in identifying central serous chorioretinopathy in their patients, as well as what treatment options are available.

A new study out of Guangzhou, China found that individuals younger than 18 years of age and experiencing high myopia are at a high risk of progressively worsening myopic maculopathy.

When a patient has low contrast sensitivity, it means they have difficulty perceiving and distinguishing objects or patterns with subtle differences in contrast. This can have several implications for their vision and daily life, since our world is not merely black and white.